Sanofi Genzyme is collaborating with Madeleine Stowe on the “Lights, Camera, Take Action on MS,” a campaign, intended to educate and empower members of the MS Community to take action to help manage their disease.
Actress Madeleine Stowe is sharing her connection to MS through a new campaign with Sanofi Genzyme. View webisodes featuring Madeleine at TakeActionMS.com.
“I remember him being a very tall man. He used to carry me on his shoulders,” said Madeleine Stowe, a TV and film actress, remembering her early years with her father. “That was before MS really took hold of him, and our family. We never knew what was around the corner – there was so much unpredictability with MS, we lived with a great deal of anxiety.”
This is not uncommon for children growing up as a care partner to a parent living with MS. Children can often experience emotions such as fear, guilt, grief, and anxiety1. Yet, while caring for someone with MS can be challenging, it can also be deeply satisfying, helping families grow closer through this shared experience.
Robert Stowe, Madeleine’s late father, was diagnosed with multiple sclerosis at a time when there were no approved treatments for the disease – and throughout the next 20 years he lived with the disease, saw a steady decline in his mobility, cognition and speech. Madeleine, her mother, Mora, and her brother and sister were his primary care partners until Robert passed away in 1983.
Though MS touched her life decades ago, Madeleine says it made a huge impact on who she is today. She is involved in healthcare education issues and human dignity issues through her charity work, and this desire to help others is what drew her to a partnership with Sanofi Genzyme, a company committed to bringing a range of treatment options to people living with relapsing MS, including AUBAGIO® (teriflunomide), a treatment for relapsing forms of MS. Through the campaign, called “Lights, Camera, Take Action on MS,” Madeleine spoke at live events across the country and online to share her connection to MS, along with neurologists and people living with relapsing MS.
“My goal in working with Sanofi Genzyme is for the Community to take inspiration from how much has changed since my father’s time. There are actions you can take to help effectively manage this disease. I look forward to hearing the different ways the MS community and their families have found ways to take action.”
Teri Evitts, a spokesperson for the campaign and part of Sanofi Genzyme’s Ambassador program, was diagnosed with relapsing MS when she was in college. That was 15 years ago.
“Initially after diagnosis, I was not aware of what could trigger or cause symptoms to worsen,” said Teri. “It has taken me years to learn to listen to my body in order to not worsen possible symptoms. I do this by not over-extending myself. I have learned over the years that stress negatively impacts my health and therefore I attempt to reduce stress in my life. That, along with my treatment – I take once-daily, oral AUBAGIO 14mg – is how I am taking action.”
To view the Take Action on MS webisodes visit www.TakeActionMS.com.
A note from MultipleSclerosis.net: The content of this article was provided by our sponsor. MultipleSclerosis.net does not specifically endorse or recommend the program, product, medications or therapies discussed in this article.
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
IMPORTANT SAFETY INFORMATION
DO NOT TAKE AUBAGIO IF YOU:
- Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
- Take a medicine called leflunomide for rheumatoid arthritis.
- Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1-800-745-4447, option 2.
- Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vaccines, vitamins or herbal supplements.
AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; serious skin problems; breathing problems (new or worsening); and high blood pressure.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.